Going with the Flow: Modeling the Tumor Microenvironment Using Microfluidic Technology

SIMPLE SUMMARY: The clinical success of cancer immunotherapy targeting immune checkpoints (e.g., PD-1, CTLA-4) has ushered in a new era of cancer therapeutics aimed at promoting antitumor immunity in hopes of offering durable clinical responses for patients with advanced, metastatic cancer. This suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hongyan, Appelt, Jackson W., Jenkins, Russell W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656483/
https://www.ncbi.nlm.nih.gov/pubmed/34885161
http://dx.doi.org/10.3390/cancers13236052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656483/
https://www.ncbi.nlm.nih.gov/pubmed/34885161
http://dx.doi.org/10.3390/cancers13236052

Ejemplares similares